Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[rkp72]

What is needed now are comments from some medical experts who are neither pumpers or bashers of the stock. From my very lay eyes, the results look interesting but not spectacular (not enough by itself to impact stock price). Clearly, more studies are needed which is going to cost more $$$. There were many expectations here that a peer-reviewed study will provide a catalyst for stock price appreciation. I don't think this is going to happen.

STSI needs cash and it needs approval of the "use" patent to move forward.

Where is the CRP study results, and whatever happened to the Pisa study? Star has been very quiet for almost a year on all of these.